Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

WAA-QOL measures impact of hair loss on women's well-being.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Taking too many vitamin and mineral supplements can cause serious health problems.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.